Of 200 MASLD-enrolled individuals, 12 were lost (5 F0–F2 and 7 AF individuals dead of extrahepatic and extra-cardiovascular events) and were thus excluded from the analysis, as well as twenty-eight not ACE-naïve patients. The gene discussed is ACE; the disease is atrial fibrillation.